RBV Capital is a private equity general partner firm headquartered in Moscow, Russia and has other offices in United Kingdom.
RBV Capital led a $11.7m Series B financing round for Bonti, a clinical-stage biotechnology company.
RetroSense Therapeutics, a MI-based clinical-stage biopharmaceutical company, secured $6m in Series B financing from RBV Capital and others.
Read more news concerning RBV Capital
A sampling of RBV Capital portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?